相关实验视频

Updated: Sep 12, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

胎儿瘤基因NUAK2是质母细胞瘤中一个新兴的治疗点

Hanhee Jo^1,2, Sarah Munoz¹, Aneesh Dalvi¹

¹Neurobiology Department, School of Biological Sciences, University of California San Diego, La Jolla, 92093, CA, USA.

EMBO molecular medicine

|August 6, 2025

概括

胎儿瘤基因NUAK2在多种质母细胞瘤 (GBM) 中重新表达. 抑制NUAK2抑制了GBM细胞的增殖和迁移,这表明它是这种侵袭性脑癌的潜在治疗标.

科学领域:

在瘤学瘤学.
神经科学是一个神经科学.
分子生物学分子生物学

背景情况:

多形质母细胞瘤 (GBM) 是一种具有较差治疗结果的侵袭性脑癌.
神经发育途径在质瘤中被重新激活,这有助于瘤的产生.
鉴定NUAK家族激酶2 (NUAK2) 是一个在GBM中重新表达的胎儿瘤基因.

研究的目的:

调查NUAK2在质母细胞瘤多种 (GBM) 瘤发生中的作用.
确定NUAK2是否是GBM可行的治疗点.

主要方法:

在GBM细胞中,CRISPR-Cas9介导的基因删除和NUAK2的过度表达.
在体外和体内生殖的增殖和迁移测试.
下游生物过程和细胞外矩阵调制的分析.
药物抑制NUAK2.2的作用

主要成果:

删除NUAK2抑制了GBM细胞的增殖,而过度表达增强了它.
AK2调节细胞外矩阵组件,促进GBM细胞迁移.
药物抑制NUAK2有效地阻碍了GBM细胞的增殖和迁移.

结论:

在GBM细胞的增殖和迁移中,NUAK2起着至关重要的作用.
努阿克2是多形质母细胞瘤的一个有希望和可行的治疗点.

关键词:

细胞外矩阵细胞外矩阵胎儿瘤基因的研究质母细胞瘤 (glioblastoma) 是一个在 NUAK2 的情况下,它是 NUAK2 .神经发育神经发育

更多相关视频

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...